2007
DOI: 10.1038/ni1440
|View full text |Cite
|
Sign up to set email alerts
|

FcγRIIb controls bone marrow plasma cell persistence and apoptosis

Abstract: The survival of long-lived plasma cells, which produce most serum immunoglobulin, is central to humoral immunity. We found here that the inhibitory Fc receptor FcgammaRIIb was expressed on plasma cells and controlled their persistence in the bone marrow. Crosslinking FcgammaRIIb induced apoptosis of plasma cells, which we propose contributes to the control of their homeostasis and suggests a method for therapeutic deletion. Plasma cells from mice prone to systemic lupus erythematosus did not express FcgammaRII… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

17
247
3
1

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 276 publications
(270 citation statements)
references
References 58 publications
17
247
3
1
Order By: Relevance
“…We have found, however, that B6.Sle1(111-148) mice produced significantly more anti-SRBC IgG and total IgG, which was correlated with a greater number of primary AFCs that downregulated surface and intracellular IgM in favor of IgG. We have confirmed recent results showing FcgRIIB expression on PC, 21 but contrary to the other autoimmune strains NZB and MRL in which FcgRIIB is virtually absent on the PC surface, the NZW allele is associated with only a modest reduction of expression on PCs. Future experiments will have to be performed to assess whether this modest reduction is sufficient to decrease PC turnover through decreased apoptosis in Fcgr2b NZW -carrying mice, as it has been shown for Fcgr2b-deficient mice.…”
Section: Resultssupporting
confidence: 88%
See 1 more Smart Citation
“…We have found, however, that B6.Sle1(111-148) mice produced significantly more anti-SRBC IgG and total IgG, which was correlated with a greater number of primary AFCs that downregulated surface and intracellular IgM in favor of IgG. We have confirmed recent results showing FcgRIIB expression on PC, 21 but contrary to the other autoimmune strains NZB and MRL in which FcgRIIB is virtually absent on the PC surface, the NZW allele is associated with only a modest reduction of expression on PCs. Future experiments will have to be performed to assess whether this modest reduction is sufficient to decrease PC turnover through decreased apoptosis in Fcgr2b NZW -carrying mice, as it has been shown for Fcgr2b-deficient mice.…”
Section: Resultssupporting
confidence: 88%
“…Future experiments will have to be performed to assess whether this modest reduction is sufficient to decrease PC turnover through decreased apoptosis in Fcgr2b NZW -carrying mice, as it has been shown for Fcgr2b-deficient mice. 21 Interestingly, the kinetics of FcgRIIB expression on PC as well as the absence of Fcgr2b NZW -specific phenotype in secondary immune responses corroborates Fcgr2b NZW allele contribution to autoimmunity ZSM Rahman et al our previous findings 15 that this receptor regulates primary T-dependent immune responses. Overall, our results indicate that Fcgr2b NZW functions as an Fcgr2b hypomorph in regulating AFC numbers and class switching independent of GC reactions.…”
Section: Resultssupporting
confidence: 56%
“…Because a significant fraction of circulating mature B cells is thought to be auto-or poly-reactive [36], such B cells may become activated because constitutive active Btk suppresses inhibitory effects of FcgRIIb or SHIP (as was previously shown for a membrane-associated Btk chimera, which led to sustained elevation of intracellular calcium [37]). In this context, it is conceivable that the E-Btk-2 Tg can also counteract inhibitory signals generated by FcgRIIb crosslinking that were recently found to induce apoptosis and thereby govern differentiation and maintenance of plasma cells [38]. Persistence of plasma cells in E-Btk-2 Tg mice would be supported by our finding of increased numbers of these cells in the BM.…”
Section: Discussionsupporting
confidence: 64%
“…It is the most broadly expressed, being found on most cells of myeloid lineage, and it is the only FcgR found on B cells. On B cells, cross-linking of FcgRIIb and the BCR activates a distinct pathway that inhibits cell proliferation, maturation, and the production of cytokines (1); however, cross-linking of FcgRIIb in the absence of the BCR initiates a bim-dependent apoptosis pathway (2). Reduced expression of FcgRIIb is associated with enhanced activation and proliferation of B cells and plasma cells (3), as well as increased Ab production to T-dependent Ags (3,4) and increased macrophage activation by immune complexes (4)(5)(6).…”
mentioning
confidence: 99%